By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


IntelGenx Corp. 

6425 Abrams Ville Street

Laurent  Quebec  H4S 1X9  Canada
Phone: 514-331-7440 Fax: 514-331-0436



Company News
IntelGenx Corp. To Report 2014 Annual Results And Provide Corporate Development Update On March 31, 2015 3/23/2015 9:56:55 AM
IntelGenx Corp. Provides Update On Sales Of Forfivo XL 2/23/2015 7:58:47 AM
IntelGenx Corp. To Present At The 8th Annual OneMedForum 1/5/2015 7:25:05 AM
IntelGenx Corp. Grants Stock Options 12/9/2014 11:04:15 AM
IntelGenx Corp. Grants Extension Of Marketing Exclusivity In The U.S. To Edgemont Pharmaceuticals, LLC. Of Forfivo XL(R) 12/5/2014 10:40:15 AM
RedHill Biopharma Ltd. (RDHL) And IntelGenx Corp. Announce Acceptance For Review Of European Marketing Application For RIZAPORT For Migraines 12/1/2014 10:30:25 AM
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014 9:16:05 AM
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014 10:17:30 AM
IntelGenx Corp. To Present At Singular Research's Best Of The Uncovered 2014 NYC Fall Conference 11/20/2014 2:01:19 PM
IntelGenx Corp. Announces Successful Clinical Study For Schizophrenia 11/3/2014 8:46:42 AM